FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4328127883> ?p ?o ?g. }

• W4328127883 endingPage "1882" @default.
• W4328127883 startingPage "1882" @default.
• W4328127883 abstract "Bile duct cancer, or cholangiocarcinoma, is a rare disease with limited treatment options that include surgery and cytotoxic chemotherapy. The high recurrence rate and poor prognosis of this type of cancer highlights the need to identify new and more effective therapeutic targets. In this study, we found that AXL, a receptor tyrosine kinase, is highly expressed in biliary cancer patients and significantly correlated with poor patient outcomes, including metastasis and low survival rates. We also demonstrated that targeting AXL inhibits tumor progression. In vitro studies with bile duct cancer cells (SNU1196 and HUCCT1) showed that genetic knockdown of AXL significantly reduced both tumor cell growth and invasion. In addition, in vivo studies using subcutaneous and orthotopic intrahepatic models demonstrated that genetic inhibition of AXL resulted in tumor-growth delay. To further examine the possible clinical translation of AXL inhibition in the clinic, we tested the efficacy of AVB-500, a soluble AXL receptor, in reducing AXL activation and tumor growth. AVB-500 was effective at inhibiting AXL activation and decreasing the growth and invasion of SNU1196 and HUCCT1 tumors which possess high AXL expression. Most importantly, AVB-500 was highly effective at decreasing tumor dissemination of bile duct tumor cells in the peritoneal cavity. This study strongly supports the idea of using the AXL receptor as a new therapeutic target to treat the growth and progression of biliary cancer." @default.
• W4328127883 created "2023-03-22" @default.
• W4328127883 creator A5010383017 @default.
• W4328127883 creator A5010636897 @default.
• W4328127883 creator A5011500068 @default.
• W4328127883 creator A5041792310 @default.
• W4328127883 creator A5054955701 @default.
• W4328127883 creator A5057589182 @default.
• W4328127883 creator A5068692519 @default.
• W4328127883 date "2023-03-21" @default.
• W4328127883 modified "2023-09-26" @default.
• W4328127883 title "Targeting AXL Using the AVB-500 Soluble Receptor and through Genetic Knockdown Inhibits Bile Duct Cancer Growth and Metastasis" @default.
• W4328127883 cites W1955926845 @default.
• W4328127883 cites W1983774108 @default.
• W4328127883 cites W1998734250 @default.
• W4328127883 cites W2025879648 @default.
• W4328127883 cites W2079075723 @default.
• W4328127883 cites W2081115093 @default.
• W4328127883 cites W2115261608 @default.
• W4328127883 cites W2129110050 @default.
• W4328127883 cites W2132286757 @default.
• W4328127883 cites W2149542744 @default.
• W4328127883 cites W2158860569 @default.
• W4328127883 cites W2235360349 @default.
• W4328127883 cites W2549442450 @default.
• W4328127883 cites W2553952769 @default.
• W4328127883 cites W2563663251 @default.
• W4328127883 cites W2566575334 @default.
• W4328127883 cites W2589049990 @default.
• W4328127883 cites W2736730167 @default.
• W4328127883 cites W2768975461 @default.
• W4328127883 cites W2784562745 @default.
• W4328127883 cites W2811028696 @default.
• W4328127883 cites W2978913650 @default.
• W4328127883 cites W2980034360 @default.
• W4328127883 cites W2982133706 @default.
• W4328127883 cites W3010157383 @default.
• W4328127883 cites W3010944770 @default.
• W4328127883 cites W3024247862 @default.
• W4328127883 cites W3132996897 @default.
• W4328127883 cites W3174179694 @default.
• W4328127883 cites W3198685471 @default.
• W4328127883 cites W4206965224 @default.
• W4328127883 cites W4211025847 @default.
• W4328127883 cites W4294203936 @default.
• W4328127883 doi "https://doi.org/10.3390/cancers15061882" @default.
• W4328127883 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36980768" @default.
• W4328127883 hasPublicationYear "2023" @default.
• W4328127883 type Work @default.
• W4328127883 citedByCount "0" @default.
• W4328127883 crossrefType "journal-article" @default.
• W4328127883 hasAuthorship W4328127883A5010383017 @default.
• W4328127883 hasAuthorship W4328127883A5010636897 @default.
• W4328127883 hasAuthorship W4328127883A5011500068 @default.
• W4328127883 hasAuthorship W4328127883A5041792310 @default.
• W4328127883 hasAuthorship W4328127883A5054955701 @default.
• W4328127883 hasAuthorship W4328127883A5057589182 @default.
• W4328127883 hasAuthorship W4328127883A5068692519 @default.
• W4328127883 hasBestOaLocation W43281278831 @default.
• W4328127883 hasConcept C101544691 @default.
• W4328127883 hasConcept C121608353 @default.
• W4328127883 hasConcept C126322002 @default.
• W4328127883 hasConcept C143998085 @default.
• W4328127883 hasConcept C157333092 @default.
• W4328127883 hasConcept C170493617 @default.
• W4328127883 hasConcept C173396325 @default.
• W4328127883 hasConcept C2775955815 @default.
• W4328127883 hasConcept C2779013556 @default.
• W4328127883 hasConcept C2779777945 @default.
• W4328127883 hasConcept C2780788601 @default.
• W4328127883 hasConcept C2909135397 @default.
• W4328127883 hasConcept C502942594 @default.
• W4328127883 hasConcept C5364575 @default.
• W4328127883 hasConcept C54355233 @default.
• W4328127883 hasConcept C71924100 @default.
• W4328127883 hasConcept C81885089 @default.
• W4328127883 hasConcept C86803240 @default.
• W4328127883 hasConcept C96232424 @default.
• W4328127883 hasConceptScore W4328127883C101544691 @default.
• W4328127883 hasConceptScore W4328127883C121608353 @default.
• W4328127883 hasConceptScore W4328127883C126322002 @default.
• W4328127883 hasConceptScore W4328127883C143998085 @default.
• W4328127883 hasConceptScore W4328127883C157333092 @default.
• W4328127883 hasConceptScore W4328127883C170493617 @default.
• W4328127883 hasConceptScore W4328127883C173396325 @default.
• W4328127883 hasConceptScore W4328127883C2775955815 @default.
• W4328127883 hasConceptScore W4328127883C2779013556 @default.
• W4328127883 hasConceptScore W4328127883C2779777945 @default.
• W4328127883 hasConceptScore W4328127883C2780788601 @default.
• W4328127883 hasConceptScore W4328127883C2909135397 @default.
• W4328127883 hasConceptScore W4328127883C502942594 @default.
• W4328127883 hasConceptScore W4328127883C5364575 @default.
• W4328127883 hasConceptScore W4328127883C54355233 @default.
• W4328127883 hasConceptScore W4328127883C71924100 @default.
• W4328127883 hasConceptScore W4328127883C81885089 @default.
• W4328127883 hasConceptScore W4328127883C86803240 @default.
• W4328127883 hasConceptScore W4328127883C96232424 @default.
• W4328127883 hasFunder F4320334626 @default.

• next